Back to top

Image: Bigstock

Patterson Companies, Inc.

Read MoreHide Full Article

We remain particularly upbeat about the growth prospects of The Patterson Companies’ Animal Health segment. Additionally the company offers a wide range of consumable supplies, equipment and software, and value-added services to its customers, which is likely to enhance the company’s growth trajectory for the long haul. Patterson Companies, Inc. exited third quarter 2017 on a stable note beating the Zacks Consensus Estimate for both earnings and sales. The upside came mainly from higher-than-expected performance in Animal Health platform business. Unfavorable foreign exchange rate and higher operating expenses are major concerns at present. The U.S. dental products distribution industry is highly competitive, which poises a major threat to Patterson Companies. Finally the stocks overvaluation reflects a relatively dull scenario that might be a cause for investors’ concern.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Patterson Companies, Inc. (PDCO) - free report >>

Published in